Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients

NCT03749356 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplant

Interventions

DRUG: TacroBell SR cap.

Sponsor

Chong Kun Dang Pharmaceutical